Pharmaceuticals, Biotechnology and Life Sciences
The Swiss-based company Geistlich Pharma AG is recalling batch of Decalcit, vitamin D and calcium chewable tablets, from the market.
Biosense Webster has acquired Coherex Medical, Inc. a privately held medical device company based in Salt Lake City, Utah.
Janssen Research & Development, LLC has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) for Invokamet extended release (XR).
Bayer has submitted an application for marketing authorization in both the European Union and in the United States for LCS-16, a new low-dose levonorgestrel-releasing intrauterine system
Sanofi and AstraZeneca have announced a direct exchange of 210,000 compounds from their respective, proprietary compound libraries.
Mylan’s subsidiaries were sued Warner Chilcott and Qualicaps in connection with the filing of an ANDA with the FDA for Mesalamine Delayed-release Capsules.
Judge Peter Kirwan of the Superior Court of California for the County of Santa Clara has granted Depomed motion for…
Sanofi will participate to Solutions COP21, the United Nations conference on climate change, as an official partner, a public exhibition in Paris.
Biofrontera has concluded the clinical phase 3 of BCC study as the last patient in the ongoing phase has had its final clinical visit.
IOLCP has completed its De-bottlenecking/ Re-engineering project for its Ibuprofen Manufacturing facilities at Barnala with project cost of Rs 24 Crores, and has started the enhanced production from Thursday.